12-15 Minutes
for Bowel Movement with ENEMEEZ®
A single-center open-label study showed the safety and efficacy of the Enemeez formulation in chronic constipation, age groups 25 to 65+, vs standard- of-care OTC or prescription laxatives. None of the patients experienced incontinent events and were free of any serious adverse effects.
Source: A single center, open-label, study to determine the safety and efficacy of DocuSol® in patients with constipation Mirela E. Ponduchi, MD (Principal Investigator) 2016
37.5%
Reduction in Incontinence
33%
Reduction in Missed Rehab Minutes
Source: Rehabilitation Hospital in Hot Springs, Arkansas Nurse-led trial
Establishing a bowel protocol using ENEMEEZ® has reduced the incidence of prolonged constipation and fecal incontinence related to the excessive use of oral laxatives and led to fewer lost therapy minutes within a rehabilitation hospital in Hot Springs, AR.
93%
Reduction in Incontinence Using ENEMEEZ® Compared to Bisacodyl
ENEMEEZ® was trialed in a model SCI facility in LA County. Fecal incontinence was observed in 3% patients using ENEMEEZ® compared to 42% using Bisacodyl.
Source: Observational Trial at Model SCI Rehabilitation Facility in LA County
57%
Reduction in bowel care time spent on incontinence-related accidents using ENEMEEZ® Compared to Bisacodyl
ENEMEEZ® was trialed in a model SCI facility in LA County. The mean duration of bowel care nursing time was reduced to 75 minutes with Enemeez compared to 118 minutes with Bisacodyl.
Source: Observational Trial at Model SCI Rehabilitation Facility in LA County
42%
Reduction in the Wound Bed at 28 days and Pain Reduction
In an observational trial, two elderly patients with painful venous stasis wounds were treated with ALOCANE®.
Both patients experienced atypical pain despite treatment in the Wound Bed with topical lidocaine, cellulose mesh dressing, and light compression. Following the initiation of ALOCANE®, both patients experienced greater pain reduction as well as improvement in wounds beds.
Sources: Homecare nurse practitioner in UT – Observational study. Braschi F, Bartoli F, Bruni C, et al. Lidocaine controls pain and allows safe wound bed preparation and debridement of digital ulcers in systemic sclerosis: a retrospective study. Clin Rheumatol. 2017;36(1):209-212. doi:10.1007/s10067-016-3414-7
Significant Pain & Itch Relief
Post-radiotherapy for Breast Cancer Patients Using ALOCANE®
In an observational trial, ALOCANE® provided relief of pain and itch associated with radiotherapy, particularly in patients with breast cancer and post radiotherapy soreness and itching.
Source: Nurse practitioner trial
3X
Perceived Oral Wetness Score Increase
With the Use of XyliMelts® For Dry Mouth while Sleeping
A study by J Burgess, and Lee P was performed to assess whether XyliMelts®, a self-adhering disc, used during sleep would reduce perceived morning oral dryness and discomfort. The study participants experienced a significant improvement in subjective wetness (P < 0.001) and a significant decrease in perceived morning discomfort (P < 0.02) with 1 week of use of the discs.
Source: Int J Dental Hygiene 10, 2012; 118-121, DOI: 10.1111/j.1601-5037.2011.00532.x; Burgess J, Lee P. XyliMelts time-release adhering discs for night-time oral dryness.
#1 Amazon Best Seller
XyliMelts® Dry Mouth Relief Product
Source: Amazon Best Sellers: Best Dry Mouth Relief Products, 07-2023
Xylimelts vs Water
In a medically complex oncology population, XyliMelts® significantly improved sleep continuity, symptom relief, and overall quality of life.
- 66.7% stopped waking at night (vs. 9.1%)
- 70% reduced need to drink overnight (vs. 20%)
- 76% reported superior dry mouth relief (vs. 24%)
- 57.6% reported improved quality of life (vs. 20%)
- 98.4% rated XyliMelts as well tolerated
#1 in America
Clinere® Ear Cleaning Tool
Source: Nielseniq
#1 Amazon Hemorrhoid Treatment
Source: Amazon Best Sellers: Hemorrhoid Cream Products, 05-2024
Request your Product Samples Today
